ReviewTherapeutic advances in medical oncology2024
Zolbetuximab for Claudin18.2-positive gastric or gastroesophageal junction cancer.
Yohei Kubota et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
43 papers cite it
this paperpooled itcites it